Subcutaneous administration of aspartic acid results in a long-lasting
but reversible depression of ventilation in male but not in female ra
ts. Aspartic acid acts on N-methyl-D-aspartate receptors. The present
study tested the hypothesis that a noncompetitive N-methyl-D-aspartate
-receptor antagonist, dextromethorphan (Dex), would depress ventilatio
n in female rats and stimulate it in male rats. Moreover, Dex administ
ered prior to aspartic acid should prevent the aspartic acid induced d
epression of ventilation in male rats. In female rats, Dex caused a 30
% depression of ventilation relative to saline at 5 and 10 mg/kg (P <
0.01) but not at the highest dose (20 mg/kg). In male rats, Dex had no
effect on ventilation. At a dose of 20 mg/kg, Dex depressed oxygen co
nsumption to 50% of the saline value at all time points in female rats
(P < 0.001) and in male rats 45 and 60 min after administration. The
time points when Dex depressed ventilation and oxygen consumption were
different in female rats, suggesting that the depression of ventilati
on was not the result of a depression in oxygen consumption. During a
hypercapnic challenge (7% CO2), female rats treated with 5 and 10 mg/k
g of Dex exhibited a smaller increase in ventilatory response relative
to saline treatment. At a dose of 20 mg/kg, the hypercapnic responsiv
eness of male rats was markedly stimulated (85.8 +/- 8.95 ml/min) rela
tive to saline (50.6 +/- 9.14 ml/min; P < 0.001). Finally, Dex adminis
tered before aspartic acid prevented the aspartic acid-induced depress
ion of ventilation in male rats. Thus, in rats, Dex has gender-specifi
c effects on ventilation and these effects are not associated with cha
nges in oxygen consumption.